US 12358921
Antiviral heterocyclic compounds
granted A61KA61K45/06A61P
Quick answer
US patent 12358921 (Antiviral heterocyclic compounds) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K45/06, A61P, A61P31/14